Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT

PETHEMA Foundation · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
multiple-myelomaobservational-studyprospective
multiple myeloma, non-eligible for autologous stem cell transplantation (asct), prospective, observational study, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 981212
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.